Agenda

CONFERENCE DAY 1
Thursday, 05 December 2019
CONFERENCE DAY 2
Friday, 06 December 2019

Registration and Welcome Coffee in Exhibition Hall

Chairperson’s Opening Remarks

Carlos Hernandez, Head of Market Insights, Abbott

Keynote: Biosimilars, Dilemma or Turkish Delight

Will cover development challenges of biosimilars, proof of similarity, regulatory and marketing obstacles, patients and healthcare professional concerns and future of biosmilar market.
Dr. Alireza Hosseini, CEO, Singapore Biotech

Making Market Research Work to Make Better Decisions

Amaredeep Udeshi, Partner, Eversana APAC

Networking & Refreshments in Exhibition Hall

An innovation way to get the true insight from customer

Hanson Zheng, Insights and Analytics Head, Sanofi

The Future Landscape in Personalised Healthcare / Precision Medicine

Jek Fong, Director, Market Access and Personalized Healthcare, Roche

Networking Luncheon

Transforming Customers’ Engagement in Healthcare

Glenda Tan, Head of Marketing, Sanofi

Clinical Trials in Cardiology using Stem Cells to Regenerate the Heart Muscle

Alexandre Civiere, Project Manager, CellProthera

How Macropolitical Drivers are Influencing Emerging ASEAN’s Healthcare Landscape

Emerging Southeast Asia's macroeconomic and political environment presents opportunities and risks for healthcare companies looking to expand in the region.

Stable economic growth and rising incomes are supporting continued increases in private spending, while governments’ attempts to expand coverage are creating opportunities (marked by pricing pressures) for companies tapping into public spending.

This session by DuckerFrontier will present key economic trends, political developments, and policy initiatives in the ASEAN-5 countries (Indonesia, Malaysia, the Philippines, Thailand, and Vietnam) and highlight their impact on the healthcare industry in the region.

Ashu Agarwal, Senior Analyst, DuckerFrontier

Presented by DuckerFrontier

Networking & Refreshments in Exhibition Hall

Q&A Open Session with Above Speakers

Networking Round Table Discussions ROUND 1

(Explore and capture the power of expert insights and experiences in this fun and informal environment.)
CONCURRENT NETWORKING ROUND TABLES OFFERED IN TWO ROUNDS. CHOOSE A TOPIC FOR ROUND 1, THEN CHOOSE THE OTHER TOPIC FOR ROUND 2.
ROUND TABLE 1
Advancing Healthcare through Innovation
Deep Tankha, Asia Pacific Sr Director Marketing, Boston Scientific




ROUND TABLE 2
The Power of Patient Insights for Strengthening Patient Engagement and Advocacy
Cindy Yu, Market Access & Government Affairs, AstraZeneca

Networking Round Table Discussions ROUND 2

ROUND TABLE 1
Advancing Healthcare through Innovation
Deep Tankha, Asia Pacific Sr Director Marketing, Boston Scientific




ROUND TABLE 2
The Power of Patient Insights for Strengthening Patient Engagement and Advocacy
Cindy Yu, Market Access & Government Affairs, AstraZeneca

Evening Socializing Events! Cocktail Reception & Networking

Registration and Welcome Coffee in Exhibition Hall

The Role of Market Research and CI in New Product Planning

Laiza Filart, APAC Regional Director, Business Intelligence, Menarini Asia-Pacific

Creating System-Centric Solutions from Deep Market Understanding: Relevance is Today’s Age

Rajat Kashyap, Commercial Director, Hologic

Networking & Refreshments in Exhibition Hall

Robotic Technology and Machine Learning

The talk will cover how recent advances in robotic technology and machine learning enable a paradigm shift in drug discovery research.

Martin-Immanuel Bittner MD DPhil, Co-Founder & CEO of Arctoris will address how collective efforts combining robotics and AI enable the emergence of a new model of data-driven drug discovery. Bringing together recent advances in life sciences automation and machine learning applications for drug discovery, new partnerships evolve that allow for game-changing improvements in the drug discovery process going beyond what is currently possible.

Martin-Immanuel Bittner, Co-Founder and CEO, Arctoris

Q&A Open Session with Above Speakers

Chairperson’s Closing Remarks and Intro of the Scenario Planning Workshop

Carlos Hernandez, Head of Market Insights, Abbott

Networking Luncheon

Scenario Planning For India: How To Help Your Decision-Makers Build Resilience Into Their Strategic Plans

The Indian economy is experiencing a rapid and significant economic slowdown.

The country’s growth trajectory—and hence its healthcare spending outlook—will depend heavily on the government’s ability and willingness to implement difficult reforms.

In this session, DuckerFrontier will lead an interactive workshop on how potential scenarios for India’s economic growth will impact healthcare companies operating in the country.

Pratima Singh, Practice Leader, Asia Pacific Research, DuckerFrontier

Presented by DuckerFrontier

Conference Concludes